skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 222193 Find in a Library
Title: U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: Current Status and Future Considerations
Journal: Forensic Science International  Volume:174  Issue:2-3  Dated:January 2008  Pages:111-119
Author(s): Donna M. Bush
Date Published: January 2008
Page Count: 9
Type: Guideline
Format: Article
Language: English
Country: United States of America
Annotation: This article describes the current status of U.S. requirements for Federal workplace drug-testing programs and outlines proposed revisions to the Mandatory Guidelines for Federal Employee Drug Testing Programs.
Abstract: Detailed guidelines are presented for urine specimen collection. Although urine specimen collection requirements are stated in the guidelines, a more detailed collection procedure is presented in the Urine Specimen Collection Handbook. The guidelines specify the required features of the collections site, the donor's responsibilities, and procedures for collecting urine specimens. Guidelines for drug testing require the use of an immunoassay test cleared by the Federal Drug Administration. If the immunoassay test is positive, indicating that the specimen contained one or more drugs tested, then confirmatory testing with gas chromatography/mass spectrometry is required in order to definitively establish the identity of the drug or drug metabolite. The required cutoffs of the guidelines for the initial and confirmatory tests are presented in a table. Guidelines for specimen validity testing are also reviewed; and current dilution, adulteration, and substitution products used in attempting to "beat" a drug test are described. The U.S. Department of Health and Human Services, which is responsible for developing and monitoring Mandatory Guidelines for Federal Employee Drug Testing Programs, continues to identify and implement the most accurate and reliable drug-testing technology available. Proposals for future consideration involve alternative specimen validity testing, certification requirements, collector requirements, requirements for Medical Review Officers, initial screening process, instrumental initial test facilities, and action following the closure of public comments on proposed guidelines. 3 tables and 13 references
Main Term(s): Drug testing; United States of America
Index Term(s): Employee drug testing; Federal regulations; Occupational safety and health; Urinalysis; US Department of Health and Human Services
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.